In endometrial carcinoma, deregulated ERα caused by genomic or epigenetic aberrations was a prevalent phenomenon, which reduced the expression of ERα and associated with extensive invasion and high-stage and poor prognosis [124, 125]. Here, ESR1 is linked to endometrial carcinoma.